Literature DB >> 18995953

Quality of life in patients with focal dystonia.

Tatjana Pekmezovic1, Marina Svetel, Natasa Ivanovic, Natasa Dragasevic, Igor Petrovic, Darija Kisic Tepavcevic, Vladimir S Kostic.   

Abstract

OBJECTIVES: The aims of this study were to identify the clinical and demographic factors influencing health-related quality of life (HR-QoL) and to compare HR-QoL measures between various types of focal dystonia (cervical dystonia, blepharospasm, and writer's cramp).
METHODS: We examined 157 consecutive patients with adult-onset primary focal dystonia, and HR-QoL was assessed by using the SF-36 questionnaire. Univariate and multivariate regression analyses were performed.
RESULTS: Patients with writer's cramp scored better in all SF-36 domains, except role functioning physical (RP), while these differences were statistically significant for physical functioning (PF) (p=0.020), bodily pain (BP) (p=0.001), and general health (GH) (p=0.004). Patients with writer's cramp and blepharospasm scored significantly better for BP (p=0.001) than patients with cervical dystonia. We found that each of the eight dimensions of SF-36 proved to be significantly correlated to the Hamilton depression rating scale score in patients with torticollis and blepharospasm, while vitality (VT), social functioning (SF), and mental health (MH) scales showed statistically significant correlations in patients with hand dystonia. Similar relationships were observed between anxiety and SF-36 domains.
CONCLUSION: Depression and anxiety are the most important predictors of poorer HR-QoL in patients with all three types of focal dystonia.

Entities:  

Mesh:

Year:  2008        PMID: 18995953     DOI: 10.1016/j.clineuro.2008.09.023

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  43 in total

1.  Botulinum toxin and occupational therapy for Writer's cramp.

Authors:  Jung E Park; Ejaz A Shamim; Pattamon Panyakaew; Pawan Mathew; Camilo Toro; Jonathan Sackett; Barbara Karp; Codrin Lungu; Katharine Alter; Tianxia Wu; Omar F Ahmad; Monica Villegas; Sungyoung Auh; Mark Hallett
Journal:  Toxicon       Date:  2019-07-24       Impact factor: 3.033

2.  [Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment].

Authors:  B Leplow; M Böttcher; R Schönfeld
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 3.  The effectiveness of physiotherapy for cervical dystonia: a systematic literature review.

Authors:  Joke De Pauw; Kevin Van der Velden; Jill Meirte; Ulrike Van Daele; Steven Truijen; Patrick Cras; Rudy Mercelis; Willem De Hertogh
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

4.  [Essential blepharospasm : Practice-oriented therapy with botulinum toxin employing reduced treatment intervals].

Authors:  B Wabbels; P Roggenkämper
Journal:  Ophthalmologe       Date:  2012-01       Impact factor: 1.059

5.  Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia).

Authors:  Ivana Z Basta; Tatjana D Pekmezović; Stojan Z Perić; Darija B Kisić-Tepavčević; Vidosava M Rakočević-Stojanović; Zorica D Stević; Dragana V Lavrnić
Journal:  Neurol Sci       Date:  2012-08-09       Impact factor: 3.307

6.  Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.

Authors:  Dursun Ceylan; Sevda Erer; Mehmet Zarifoğlu; Nevin Türkeş; Güven Özkaya
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

7.  The role of the trigeminal sensory nuclear complex in the pathophysiology of craniocervical dystonia.

Authors:  Lynley Bradnam; Christine Barry
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

8.  Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm.

Authors:  Bettina Wabbels; Gerhard Reichel; Antony Fulford-Smith; Nicola Wright; Peter Roggenkämper
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

Review 9.  Psychiatric comorbidities in dystonia: emerging concepts.

Authors:  Mateusz Zurowski; William M McDonald; Susan Fox; Laura Marsh
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 10.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.